NewCo to get DSM Biologics and Australian plant says Royal DSM

By Gareth Macdonald contact

- Last updated on GMT

NewCo to get DSM Biologics Australia plant
NewCo to get DSM Biologics Australia plant

Related tags: Australia, Dsm pharmaceutical products

Royal DSM has confirmed that its biologics manufacturing operations and new Australian facility will be part of the business merged with Patheon in its agreement with JLL.

In November last year DSM announced that it will combine its pharmaceutical products business (DPP) with contract manufacturing organisation Patheon, bringing to an end several years of efforts to find a partner for the underperforming division​.

Earlier today DSM spokesman Herman Betten told BioPharma-Reporter.com that DSM Biologics – which is part of the firm’s pharmaceutical unit – will be part of the new combined company and that the recently opened biomanufacturing facility in Brisbane would be included.

The plant, which has been operational since June last year​, was constructed in partnership with the Australian Institute for Bioengineering and Nanotechnology (AIBN).

Betten also said that the official name of the combined firm – which is currently being referred to as NewCo – will be revealed when the deal is completed.

Improved performance

DSM’s plans for DPP also featured in the Dutch firm’s results release issued earlier today. The business is now listed as a discontinued operation.

The firm said that: “DSM Pharmaceutical Products delivered an improved performance in the quarter, with good volume growth and higher prices being reflected also in good EBITDA growth.

This performance will support a good start for the value-creating venture with JLL Partners​.” 

Related news

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars